Objective/background: Despite several studies on health system delay (HSD) among tuberculosis (TB) patients in Nigeria, no study has compared HSD in private and public health facilities. This study assessed the determinants of HSD in public and private health facilities offering the directly observed treatment, short course (DOTS).
Introduction
Tuberculosis (TB) remains a serious public health problem in Nigeria despite the implementation of the directly observed treatment, short course (DOTS) strategy over two decades ago [1] . Nigeria ranks fourth among the 22 countries with high TB burden worldwide [2] , with a TB prevalence of 318/100,000 population [1] ; however, the country notifies less than onefifth of the estimated TB prevalence [3] . Reports from the 2012 TB prevalence survey showed that a majority of TB patients had not visited a health-care facility; and even if they did, they were not readily diagnosed as having TB [1] . This could contribute to continued transmission within the community.
One of the strategies of the National Tuberculosis and Leprosy Control Programme aimed at increasing TB case finding by improving access to TB diagnosis and treatment and reducing delay in accessing care by engaging all private practitioners in the public-private mix (PPM). This was expected to link all health-care providers in the private and public sectors to the National Tuberculosis Programme (NTP) in line with the STOP TB strategy [4, 5] . Despite this effort, health system delay (HSD) among TB patients in Nigeria was longer than other high TB-burden countries [6] [7] [8] [9] [10] [11] , although a systematic review [12] showed that there was no significant difference in the mean HSD between low-and middle-income countries and high-income countries.
According to the World Health Organization determinants of TB control, risk factors of delayed diagnosis can be divided into socioeconomic, clinical, and health system factors [13] . Systematic reviews and meta-analysis from developed and developing countries have demonstrated the determinants of HSD [14] [15] [16] . However, no study to the best of our knowledge has examined the determinants of HSD at public and private DOTS facilities. This study therefore assessed these determinants at public and private DOTS facilities under the Lagos State TB and Leprosy Control Programme (LSTBLCP).
Methods

Study design
A descriptive cross-sectional study was conducted to assess the determinants of HSD at public and private DOTS facilities in Lagos State, Nigeria.
Study background
Lagos State is located in southwest Nigeria. It is the most commercialized state of the country. A total of 20 local government areas (LGAs) and 37 local council development areas were established in the state [17] . Although it is the smallest state in Nigeria in terms of land mass, with an area of 356,861 ha, of which 75,755 ha are wetlands, it has a population of 21 million [17] . The population growth and population density (2012) of Lagos are about 600,000/year and 4193 persons/km 2 , respectively. The poverty rate in the state is about 64.1% (using dollar/day poverty) and the poverty gap index is 0.347. The human development index and human poverty index for the state are 0.607 and 14.5, respectively. Unemployment rate in Lagos is 19.5%, the Gini coefficient is 0.643, and the adult literacy rate for male and female is 94% and 85%, respectively [18, 19] .
TB control in Lagos State
Health-care services in Lagos State were provided by both public and private sectors. Of the 2269 registered healthcare facilities in the state in 2012, 1981 (87.3%) were from the private sector. TB control in Lagos State is coordinated by the LSTBLCP. The DOTS management of TB started in Lagos State in 2003 and the PPM for TB management commenced in 2008. By 2012, 31 private practitioners had been engaged in the PPM. Private DOTS providers were engaged to refer patients suspected of having TB, provide DOTS treatment, served as an approved microscopy center or served as both microscopy and treatment center [20] .
TB treatment is free in the state; however, patients managed at the private DOTS facilities were charged for consultation and laboratory test. Those managed at the public DOTS facilities were also required to pay for any other laboratory tests other than sputum acid-fast bacilli and GeneXpert. Treatment duration was 8 months and the treatment regimen consisted of 2 months' intensive phase of rifampicin, isoniazid, pyrazinamide, and ethambutol as fixed-dose combination and 6 months' continuation phase of rifampicin and isoniazid as fixed-dose combination. Patient's treatment could either be supervised by health workers at the DOTS facility or treatment supporter chosen by the patients. To reduce loss to follow-up, patients diagnosed with TB were managed at the DOTS facility nearest to their residents.
All presumptive TB clients were offered human immunodeficiency virus (HIV) test in accordance with the HIV testing and counseling policy in the country. Determine (Alere Determine HIV-1/2 test, Matsuhidai Matsudo-shi, Chiba-ken, Japan) and Uni-Gold (Trinity Biotech PLC, Wicklow, Ireland) were used in parallel algorithm. STAT-PAK (Chembio diagnostic systems Inc., Medford, Newyork, USA) was used as a tie breaker if a discordant result was obtained. The HIV test was done free of cost for patients managed at either private or public DOTS facility. TB/HIV co-infected patients were offered co-trimoxazole in addition to anti-TB drugs.
Each DOTS facility is managed by a TB focal person who is responsible for the day-to-day running of the facility and for ensuring that patient's records are intact. The records of all TB patients in DOTS facilities within an LGA are sent to the state TB program by the LGA TB supervisor at the end of every quarter [21] .
Population and sample
From the sampling frame of 130 (99 public and 31) DOTS facilities provided by the Lagos State program officer, all the DOTS facilities (34 comprising 23 public and 11 private) that served as both microscopy and treatment centers and that had been involved in the DOTS program under the LSTBLCP for at least 2 years prior to data collection were recruited into the study. Newly diagnosed TB patients aged above 14 years having at least one sputum smear-positive result were consecutively recruited between October 1, 2012, and December 31, 2012 (last quarter of 2012), from the selected DOTS facilities. Details of the sample size calculation were published elsewhere [22] .
Study procedure
On recruitment into the study, a structured pretested interviewer-administered questionnaire was completed by the patients after they provided written informed consent. Data relating to places visited after the onset of symptoms, clinical signs and symptoms and their duration, interval between onset of symptoms and first visit to the doctor, interval between first visit to the doctor and initiation of treatment, nature of health facility first visited, and whether treatment was supervised by treatment supporter or by health worker at the DOTS facilities along with other sociodemographic details of patients were obtained. The questionnaire was developed after reviewing relevant literatures and the NTP's DOTS worker's manual [21, 23] . Patient interview was conducted within the 1st week of treatment initiation to reduce recall bias.
Definition of outcome variable
HSD was defined in this study as the interval between the first contact of a presumptive TB patient with a health facility and the diagnosis of TB [12] . A cutoff of 15 days was used to indicate prolonged HSD [24] .
Data analysis
The Statistical Package of Social Sciences (version 19; IBM, Armonk, NY, USA) was used for data analysis. Percentages, median, and interquartile range (IQR) were used to describe the outcome variable (HSD). Normality of the outcome variable was assessed using a histogram plot and appropriate statistical test was used based on the distribution. A chisquare test was used to compare categorical variables. Mann-Whitney U test was used to compare median HSD. Binary logistic regression was used to assess the determinants of HSD. All (independent) variables that were significant (p < .05) on bivariate analysis were entered at once (enter method) at the beginning to assess their predictive ability while controlling for the effect of other variables in the model. 
Results
Sociodemographic characteristics and clinical presentation of TB patients
In this study, 470 smear-positive TB patients were recruited. The mean age of these patients was 33.0 ± 11.6 years. Of these, 285 patients (60.4%) were less than 35 years of age, 280 (59.6%) were males, and 231 (49.1%) were married. Fortyeight patients (10.2%) had TB/HIV co-infection; 358 (76.2%) were treated at the public DOTS facilities, and the remaining 112 (23.8%) were treated at the private DOTS facilities. As much as 140 (30%) and 245 (52.1%) TB patients visited the private and public hospitals, respectively, when they first developed symptoms of TB. Others either went to the drug store (5.3%), traditional healers (3.0%), or did self-medication (9.8%; Table 1 ). 
HSD of TB patients
The overall median HSD of TB patients managed at both public and private DOTS facilities was 14 days (IQR 10-20 days Patients' characteristics associated with HSD Table 3 shows patients' characteristics associated with HSD. Age, DOTS facilities where patients were managed, HIV status, income, and place first visited by TB patients when they first developed symptoms of TB were associated with prolonged HSD longer than 14 days (p < .05). Direct logistic regression was performed to assess the impact of age, type of DOTS facility, HIV status, health facility first visited, and income on the likelihood of prolonged HSD. The full model containing all predictors was statistically significant (v 2 6 = 56.74 [N = 441], p < .001). The model as a whole explained between 27.1% (Cox and Snell R 2 ) and 36.3% (Nagalkerke R 2 ) of the variance in HSD and correctly classified 74.6% of cases. The strongest determinant of prolonged HSD was first visit to a nonhospital facility (odds ratio [OR] 4.12; 95% CI 2.52-7.549). TB patients who first visited a nonhospital facility were over four times likely to have prolonged HSD than those who first visited government hospital when they first developed symptoms. Other determinants of prolonged HSD were treatment at the public DOTS facilities, TB/HIV co-infection, and lower income. Patient treated at the public DOTS facilities had twofold chance of having prolonged HSD (OR 2.086; 95% CI 1.455-3.765) than those managed at private DOTS facilities. In addition, those with TB/HIV co-infection (OR 3.134; 95% CI 1.605-6.102) and those who first visited private hospital when they first developed symptoms of TB (OR 2.975; 95% CI 1.756-5.039) were three times likely to have prolonged HSD than HIV-negative patients and those who first visited public hospital when they first developed symptoms of TB. However, those who did not visit any health facility when they first developed the symptoms of TB (OR 4.123; 95% CI 2.252-7.549) and those who earned less than US $125 monthly (OR 3.852; 95% CI 1.406-10.549) had a fourfold chance of having prolonged HSD compared with those who visited the public hospital when they first developed symptoms of TB and those who earned above US $125 monthly, respectively, as shown in Table 4 .
Discussion
Health-care-seeking behavior of TB patients A majority of the TB patients in this study visited the public rather than the private hospital when they first developed symptoms of TB. This finding is contrary to what was reported in studies from Nigeria and elsewhere where TB patients sought health care first at private health facilities [8, [25] [26] [27] . Out-of-pocket payment for health-care services is the major source of health-care financing in Nigeria [28] and this may explain why a majority of the TB patients in this study visited the public rather than the private hospital when they first developed symptoms of TB. TB awareness creation by the LSTBLCP, introduction of treatment supporters in TB management, and engagement of community volunteers in active case finding may be also be responsible for this behavior.
Median HSD at public and private DOTS facilities
In our study, the overall reported median HSD was 14 days (IQR 10-20 days) and about 25% of the patients recruited had HSD of more than 14 days. This finding is low compared with studies from Nigeria and other low-and middle-income countries that documented longer time for HSD [12, 25, 29] . Knowledge of health-care workers and availability of laboratory reagents and supplies at the public and private DOTS facilities may be responsible for this finding. Diagnosis of TB depends on adequate training of health-care workers and availability of diagnostic facilities [16] , especially in patients without classical signs and symptoms of TB [30, 31] . Although studies from Nigeria, Pakistan, and India have shown that private practitioners lacked adequate knowledge of TB management [32] [33] [34] [35] , there was no significant difference in the knowledge of health-care workers at the private and public facilities engaged in the PPM for DOTS management in Nigeria [36] . The median HSD at public DOTS facilities was longer than private DOTS facilities (p = .002) in this study. A higher proportion of TB patients managed at public DOTS facilities had HSD more than 14 days (p = .013) and the odds of having HSD longer than 14 days were two times higher at the public DOTS facility than the private DOTS facilities (OR 2.1; 95% CI 1.2-3.8). The higher volume of patients seen at the public DOTS facilities and the cumbersome bureaucracy, which characterized public hospitals, may explain this finding. In addition, because of the low volume of patients at private DOTS facilities, laboratory reagents and supplies were more readily available in these facilities than in public DOTS facilities in Lagos, Nigeria [37] . This implies that TB diagnosis will be faster at private DOTS facilities. There is also the possibility that patients retained and treated at the private DOTS facilities presented with classical signs of TB, whereas those with nonclassical presentations were referred to secondary and tertiary health facilities with better diagnostic equipment and specialized health personnel.
Determinants of HSD at the public and private DOTS facilities
Similar to the findings from previous studies, the first visit to private and traditional practitioner when the symptoms first appeared was associated with longer HSD than the first visit to public health facility in this study [38] [39] [40] . Unlike the private hospitals, laboratory tests such as sputum acid-fast bacilli and chest X-ray done in public hospitals are usually accepted at DOTS facilities. Therefore, patients who visited public hospital first are more likely to have shorter HSD because they do not have to repeat some of the laboratory tests done previously.
At the public DOTS facilities, TB/HIV co-infected patients and patients older than 35 years had significantly longer HSD. A systematic review on HSD and a study from Nigeria reported similar findings [16, 29] . Those aged 35 years and above are likely to be engaged in paid employment and thus need to obtain permission from their managers. As a result, they may be unable to make scheduled appointments, which may increase HSD. In addition, fear of stigma may also contribute to HSD [39] . The shock experienced by patients diagnosed with HIV and the time required to come to terms with the diagnosis may have contributed to the longer HSD among TB/HIV co-infected patients.
Women managed at private DOTS facilities took longer time to receive TB treatment than men (p = .035). This is in keeping with findings from Tanzania, Spain, and Turkey where women remained untreated for a longer time than men [41] [42] [43] [44] , but contrary to what was reported in studies from Brazil and Nigeria [8, 45] . Financial dependence of women on their spouses and family limits their access to TB services [46] and may be responsible for this finding.
Lower monthly income (<US $125) was a predictor of HSD more than 14 days in this study. TB patients with lower income had about fourfold chance of having HSD longer than 14 days (OR 3.85; 95% CI 1.41-10.55) than patients with relatively higher income. At the private DOTS facilities, lower income earners took longer time to commence TB treatment than higher income earners (p = .009). Private health-care facilities, unlike the public facilities, are profit driven; although TB drugs are given to patients free of cost in the LSTBLCP, they have to pay for laboratory test. In addition, inability to pay for laboratory test has been shown to delay treatment [47] [48] [49] .
Limitations
This study relied on patient recall, however, data were collected as soon as the patient was enrolled on treatment to minimize recall bias. Patients who were managed at private DOTS facilities may differ significantly in certain characteristics from those managed at public DOTS facilities and this may constitute potential bias in this study. This may be resolved by randomization of patients into private and public DOTS providers. However, the study was designed to assess the determinants of HSD at public and private DOTS facilities under programmatic conditions.
Conclusion
Determinants of HSD at the public and private DOTS facilities vary. There is a need to address all social, economic, and bureaucratic issues responsible for prolonged HSD at the public and private DOTS facilities of the LSTBLCP in Nigeria.
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